StockData
Crescent Biopharma, Inc. logo

Crescent Biopharma, Inc. (CBIO) dividend history

CBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 10/30
$14.15−0.22 (-1.53%)

Close on Nov 13, 2026Market cap $525.59MP/E –Yield –

Dividend payments

Every dividend Crescent Biopharma has paid, newest first. Shares held at the close of the last day with dividend receive it; shares bought on the ex-dividend date or later do not.

Ex-dividendLast day to buyRecordPayableDeclaredPer shareSource
Jan 13, 2023Jan 12, 2023–––$24.0010-Q
Sep 21, 2022Sep 20, 2022–––$143.0010-Q

Per share as declared at the time. Source document: the dividend announcement filed with the SEC (press release or 8-K) where one exists, otherwise the quarterly or annual report covering the declaration.

See a number that looks wrong?